Reduction of lymphocyte count at early stage elevates severity and death risk of COVID-19 patients: a hospital-based case-cohort study

INTRODUCTION: Several reports have noted that severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induced lymphopenia in coronavirus disease 2019 (COVID-19) patients. However, the clinical significance of lymphopenia remains unclear. The objective of this study was to analyze the associatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Fei, Jun, Fu, Lin, Li, Ying, Xiang, Hui-Xian, Xiang, Ying, Li, Meng-Die, Liu, Fang-Fang, Xu, De-Xiang, Zhao, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507779/
https://www.ncbi.nlm.nih.gov/pubmed/37732034
http://dx.doi.org/10.5114/aoms.2020.99006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507779/
https://www.ncbi.nlm.nih.gov/pubmed/37732034
http://dx.doi.org/10.5114/aoms.2020.99006

Ejemplares similares